$4.62
-0.21-4.35%
가까이에: Nov 17, 4:00 PM EST
$4.62
-0.21-4.35%
프리마켓: 3:00 AM EST

The average analyst price target for Evolent Health is $10.78, 133.3% above the current price. Of 16 analysts, 14 rate it Buy and 2 Hold. Targets range from $3 to $28. The latest change came on Nov 6, 2026, when Oppenheimer raised its price target on Evolent Health from $6 to $7 and kept an Outperform rating.
Price Target Range — 13 Quarters
Analyst Consensus — 16 Analysts
Rating Trend — Last 9 Months